Luteolin inhibits human keratinocyte activation and decreases NF-κB induction that is increased in psoriatic skin.
Psoriasis (Ps) is an autoimmune disease characterized by keratinocyte hyperproliferation and chronic inflammation, with increased expression of tumor necrosis factor (TNF) and vascular endothelial growth factor (VEGF). Anti-TNF biologic agents are effective in treating Ps, but are associated with in...
Main Authors: | Zuyi Weng, Arti B Patel, Magdalini Vasiadi, Anastasia Therianou, Theoharis C Theoharides |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0090739&type=printable |
Similar Items
-
Luteolin as a therapeutic option for multiple sclerosis
by: Theoharides Theoharis C
Published: (2009-10-01) -
N-eicosapentaenoyl-ethanolamine decreases the proliferation of psoriatic keratinocytes in a reconstructed psoriatic skin model
by: Mélissa Simard, et al.
Published: (2023-07-01) -
Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin
by: Asadi Shahrzad, et al.
Published: (2012-05-01) -
Neurotensin is increased in serum of young children with autistic disorder
by: Angelidou Asimenia, et al.
Published: (2010-08-01) -
Depletion of G9A attenuates imiquimod-induced psoriatic dermatitis via targeting EDAR-NF-κB signaling in keratinocyte
by: Zhiqin Fang, et al.
Published: (2023-09-01)